Livostin 0.025%

Livostin 0.025% Uses, Dosage, Side Effects, Food Interaction and all others data.

Livostin 0.025% is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Livostin 0.025% was discovered at Janssen Pharmaceutica in 1979.

Livostin 0.025% is a selective histamine H1-receptor antagonist exerting inhibitory effects on the release of chemical mediators from mast cells and on the chemotaxis of polymorphonuclear leukocytes and eosinophils. Both histamine and antigens induced conjunctivitis can be inhibited by levocabastine. Livostin 0.025% can also reduce symptoms of allergic rhinitis by preventing an increase in vascular permeability of nasal mucosa.

Table Of contents

• Livostin 0.025%
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Livostin 0.025%
Generic	Levocabastine
Levocabastine Other Names	Levocabastina, Levocabastine, Levocabastinum
Type
Formula	C26H29FN2O2
Weight	Average: 420.528 Monoisotopic: 420.221306345
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country	Japan
Last Updated:	September 19, 2023 at 7:00 am

Uses

Livostin 0.025% is a selective histamine H1 receptor antagonist indicated for the management of seasonal allergic conjunctivitis symptoms.

As an ophthalmic for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. Also used as a nasal spray for allergic rhinitis.

Livostin 0.025% is also used to associated treatment for these conditions: Allergic Rhinitis (AR), Conjunctivitis allergic

How Livostin 0.025% works

Livostin 0.025% is a potent, selective histamine H1-receptor antagonist. It works by competing with histamine for H1-receptor sites on effector cells. It thereby prevents, but does not reverse, responses mediated by histamine alone. Livostin 0.025% does not block histamine release but, rather, prevents histamine binding and activity. Livostin 0.025% also binds neurotensin 2 receptors and serves as a neurotensin agonist. This can induce some degree of analgesia.

Toxicity

Adverse effects include visual disturbances, dry mouth, cough, nausea, eyelid edema and lacrimation.

Food Interaction

No interactions found.

Elimination Route

After instillation in the eye, levocabastine is systemically absorbed, albeit at low levels.

Half Life

36 hours (after oral administration)

Innovators Monograph

You find simplified version here Livostin 0.025%